THA’s Alan Foreman Joins All-Baffert Controversy Writers’ Room

Normally, the TDN Writers' Room podcast presented by Keeneland aims to touch on a wide variety of industry issues every week. But there was only one story worth discussing this week, so the writers broke down every angle of the explosive controversy surrounding Bob Baffert and the failed drug test of GI Kentucky Derby winner Medina Spirit. They also welcomed Thoroughbred Horsemen's Association Chairman and CEO and prominent industry lawyer Alan Foreman as the Green Group Guest of the Week to talk about what happens now for Baffert from a legal standpoint.

“I think it's important for people to understand that there are two layers here,” Foreman said about the fallout of this week. “This is a state regulatory matter and the regulation is done by the Kentucky Horse Racing Commission. What Churchill Downs did [banning Baffert from the entry box] was more of a public relations stand to protect the Kentucky Derby brand that they covet. Tracks have the common law right to exclude anyone they want, but when you're dealing with licensees, it isn't as broadly based as you would think it is. There's quite a body of law with respect to the exclusion of licensees and what should be appropriate circumstances. The question here legally would be if Bob Baffert and his team wanted to challenge it, whether Churchill Downs really has the right to do so under the circumstances. This is a routine medication violation. If they're going to ban Bob Baffert, do you ban every horseman who has some medication violation?”

Asked about the frequent public appearances by Baffert to talk about a situation that's still being litigated, particularly his revelation Tuesday that Medina Spirit was treated with a cream that contained betamethasone, Foreman said, “I don't know what their strategy is. I don't know if this is what Bob wanted to do or if he was under advice to do it. The information that came out [Tuesday] changes the whole landscape. The first thing that you do if you're a trainer and you're notified of a positive test, is ask your personnel and veterinarian, do we have betamethasone in the barn? You would know that fairly quickly, you wouldn't know it 48 to 96 hours after the fact. You certainly wouldn't go on television and say, 'I don't use the stuff. We don't have it in the barn. I don't know how it got there. It's everybody else's fault.' That's basic stuff. So the strategy makes no sense to me and I certainly wouldn't counsel my clients that way.”

Elsewhere on the show, which is also sponsored by West Point Thoroughbreds, the Minnesota Racehorse Engagement Project and new sponsor Legacy Bloodstock, the writers called out the decisions and behavior that led to the embarrassment this past week has brought racing, debated what can be done now and reacted to the decision to allow Medina Spirit's entry in the Preakness. Click here to watch the podcast; click here for the audio-only version.

The post THA’s Alan Foreman Joins All-Baffert Controversy Writers’ Room appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Mid-Atlantic Sees Significant Drop In Racing Fatalities Following Reforms

COVID-19 forced Thoroughbred racing into what was for most a two-month hiatus, but the stakeholders in the Mid Atlantic turned the down time into an opportunity to focus on its Strategic Plan to Reduce Equine Fatalities.

Regulators, racetracks, horsemen's and breeders' groups representing all seven states in the region – Delaware, Maryland, New Jersey, New York, Pennsylvania, Virginia, and West Virginia – committed to the Mid-Atlantic Strategic Plan to Reduce Equine Fatalities in 2019. Collectively, they have been working to adopt regulations, protocols and best practices to enhance the safety and integrity of the sport. Their efforts are having an impact. The equine fatality rate in the region has dropped from 1.78 per thousand starts in 2019, to 1.21 per thousand to date this year, a decrease of 33%.

The architects of the Strategic Plan, Thoroughbred Horsemen's Association Chairman Alan Foreman and New York State Equine Medical Director Dr. Scott Palmer, provided a progress report on the efforts of the Mid-Atlantic stakeholders Wednesday.

“It is heartening to see that the commitment and hard work of so many in the Mid Atlantic is bearing fruit,” Foreman said. “We have representatives from every faction of the Thoroughbred industry in the region at the table. Everyone has the chance to be heard and their specific issues considered. We are proud to say that, working together, we have been able to make significant advances on issues of medication reform and horse health.”

Dr. Palmer remarked, “In a climate of polarity and discord, the efforts in the Mid Atlantic serve as a shining example of what we can accomplish when we are united behind the cause of equine safety and welfare.”

Every state in the Mid Atlantic has adopted the following reforms:

  • A prohibition on NSAID “stacking” – the use of more than one NSAID the week of a race
  • Transfer of joint injection records for claimed horses
  • Necropsies on equine fatalities
  • Mortality Review Board
  • Voidable claim rules

Dr. Tim Parkin, a renowned epidemiologist from the University of Glasgow, released the findings of his latest study using data from The Jockey Club's Equine Injury Database in June, noting that those tracks that have instituted a void claim rule in the last 10 years saw a 27% decrease in equine fatalities for those races. The states in the Mid Atlantic have all implemented this additional layer of protection; claims are voidable at the discretion of the claimant if the horse is vanned from the track after the race or is observed to be lame prior to delivery to the new trainer.

Additional reforms have been implemented in all states except West Virginia, including:

  • 48-hour withdrawal time for NSAIDs
  • Enhanced penalties for NSAID overages
  • 14-day withdrawal for joint injections

The West Virginia Racing Commission considered legislation to adopt the new guidelines for NSAIDs and joint injections, but it ultimately was voted down by the Commission.

“We are disappointed that West Virginia remains an outlier in this area,” Foreman said. “Regulatory changes in the state must go through the legislature, which takes time, but we will continue to work with all parties to get this done.”

There is a strict prohibition on the use of bisphosphonates in all horses under the age of four throughout the region, with a total ban in place in Maryland and Pennsylvania. In May, the Mid Atlantic agreed to adopt restrictions on the use of thyroid supplements, now requiring that a horse be diagnosed with hypothyroidism through a thyroid releasing hormone stimulation test; the treatment plan must be reviewed and approved by the equine medical director or chief regulatory veterinarian in the state. In October, the group moved to restrict the use of clenbuterol. The new rule requires regulatory approval for treatment with clenbuterol, mandates that the horse be placed on the Veterinarian's List, and bars the horse from racing until it tests negative in both blood and urine and completes a satisfactory workout observed by a regulatory veterinarian.

In addition to the regulatory changes, the Mid Atlantic has approved Best Practices in a dozen areas, including:

  • Biosecurity
  • Crisis Management Communication
  • Equine Aftercare
  • Layoff Report
  • Pre-Race Inspections
  • Safety Officer
  • Shock Wave Therapy

Maryland led the charge on the mandatory Layoff Report, a standardized form that provides regulatory veterinarians with vital information for all horses that have not raced for 150 days or more, including the reason for the layoff, medication and joint injection records, and surgical reports. The Layoff Report has been fully implemented in Delaware, Maryland, Virginia and West Virginia, and is in process throughout the Mid Atlantic.

The most high-profile of this year's changes has been the crop rule. The stakeholders in support of the Strategic Plan created a Committee of 24 regulators and stewards to review the many proposals on the table. All interested parties were invited to participate, with the Jockeys' Guild providing significant input during a series of conference calls. A draft was approved during a presentation to more than 50 representatives of the region's racetracks, horsemen's groups and regulatory agencies.

The draft underwent one final review after the Kentucky Horse Racing Commission approved a rule June 19, and was modified once more to align with provisions in the Kentucky rule. Starting Aug. 1, the rule went into effect in Delaware and Maryland. Pennsylvania followed suit in October. West Virginia has begun the legislative process necessary to adopt it in 2021.

“Uniformity has been a hallmark of the efforts in the Mid Atlantic for more than a decade, going back to the ban on anabolic steroids in 2008,” Foreman said. “Our annual Regulatory meetings have grown year after year, with the focus expanding from medication and testing to include equine welfare and racing integrity. The crop rule is a natural extension of our efforts. We felt it imperative to have a consistent crop rule in every jurisdiction, and we made every effort to ensure that all stakeholders had the chance to weigh in on it.”

A 30-page Strategic Plan Manual, still a work in progress, has been created as a reference for all Mid-Atlantic jurisdictions. There is also a Horsemen's Guide to the Strategic Plan, providing an overview of the regulations and best practices that impact the day-to-day business of training Thoroughbred racehorses.

A second Guide outlines the Risk Factors that have been identified through Dr. Parkin's work with the Equine Injury Database and the Grayson-Jockey Club Research Foundation, which horsemen can use to assess their stable and modify care and treatment as necessary for horses at increased risk.

“From day one when concept of the Strategic Plan was first under discussion, this has been a collaborative effort, with all of our stakeholders focused on one thing – doing what is right by the horse,” said the Strategic Plan's Project Manager, Andy Belfiore. “The level of dedication and the amount of time and energy devoted to this initiative from all involved has been remarkable. It has taken a lot of work from the regulators and the state veterinarians, to racetrack's management teams, to the owners and trainers and jockeys, to get to where we are today.”

As the first phase of the Strategic Plan nears completion, the focus turns to the topics including the racetrack maintenance quality system; jockey health; the transfer of horse health records for all claimed horses; and continuing education.

Dr. Kelly Ryan of MedStar Horsemen's Health in Maryland worked with HeadCheck Health to develop a system that establishes concussion protocols for jockeys, as well as providing a HIPAA-compliant portal for jockey health information, and a communications network to ensure that all racetracks on the system are notified if there is an accident or injury affecting a jockey's status to ride. Maryland began a pilot program last fall, and Delaware Park enrolled its riders when racing resumed this spring. Additional jurisdictions are now working with HeadCheck to explore implementation, with the goal of having every Mid-Atlantic racetrack on the network by next year.

The Mid-Atlantic alliance unanimously approved a Continuing Education rule that will go into effect in 2021. Trainers and assistant trainers will have a year to fulfill the requirements, which include four hours annually of CE training, with a minimum of two hours to focus on equine health, safety and welfare. Fulfillment of CE requirements will be a condition of licensing in 2022 for all Mid-Atlantic states. New York already has a CE rule on the books, Maryland has begun the adoption process, West Virginia included it in its legislative package for 2021, and the remaining states have committed to adoption next year.

“New York has been a leader in many areas, including Continuing Education, but the Mid-Atlantic Strategic Plan is not about one jurisdiction calling the shots for the entire region,” Dr. Palmer concluded. “Working together, we have been able to reach consensus. We have right-minded people in the room who want to do the right thing, and we have a track record for getting things done. What we've accomplished is amazing, and we look forward to continued progress in the coming year.”

The post Mid-Atlantic Sees Significant Drop In Racing Fatalities Following Reforms appeared first on Horse Racing News | Paulick Report.

Source of original post

THA Addresses Proposed Horseracing Integrity & Safety Act

The Thoroughbred Horsemen’s Association issued a statement Tuesday regarding the proposed Horseracing Integrity and Safety Act, which was announced Monday and is expected to be introduced in the Senate this month.

THA Chairman Alan Foreman said: “For the past year, the THA has been actively involved with industry leaders in seeking solutions to our medication issues and in enacting rules, policies and protocols to enhance the health, safety and welfare of our horses.

It has been our widely-expressed view that the original Horseracing Integrity Act, as proposed, should encompass mandatory equine safety and welfare standards for all racetracks and horsemen, and the creation of an investigative and enforcement arm of the industry.

While we have yet to see the proposed legislation, it appears that in his Horseracing Integrity and Safety Act, Senator McConnell has substantially incorporated our views. We intend to continue to be a constructive participant since the legislation, if enacted, will require substantial industry support and assistance.

Our Association has been a national leader in promoting equine health and safety protocols through the Mid-Atlantic Strategic Plan to Reduce Equine Fatalities and we expect to continue in that role.”

 

The post THA Addresses Proposed Horseracing Integrity & Safety Act appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

MD Commission Pushes Back on Lasix-Free 2YOs, The Stronach Group Vows to Write No Juvenile Races

After the Maryland Racing Commission (MRC) on Thursday refused to vote or otherwise rule on a late agenda request to allow The Stronach Group (TSG) to card Lasix-free races for 2-year-olds, an attorney for the TSG-owned Maryland Jockey Club (MJC) told the commission that the MJC-owned Laurel Park wouldn’t be scheduling any juvenile races at all under the present rules that allow the use of the controversial anti-bleeding medication.

“We currently [don’t] have, and I don’t believe we will have, any intent of carding a 2-year-old race under the condition of the administration of Lasix,” said Alan Rifkin, the MJC’s lawyer. “Our position on Lasix isn’t going to change.”

With over 100 juveniles currently in training at Laurel and no races for 2-year-olds yet run or on the horizon in the state, Rifkin’s avowal prompted commissioner Thomas Bowman to predict a short-term “devastating effect on Maryland racing, because the horses are going to have to go out of state to run.”

Alan Foreman, the chairman/chief executive officer of the Thoroughbred Horsemen’s Association (THA), whose members include Maryland owners and trainers, said TSG did not approach horsemen or breeders in advance of bringing the matter up before the commission June 25.

“We suspected something was up weeks ago because they weren’t carding 2-year-old races,” Foreman said, adding that the THA reached out to TSG officials for an explanation. “We couldn’t get an answer. We waited weeks to get an answer. We kept getting bounced around.”

Foreman continued: “So here we have, in the middle of the COVID pandemic, the horsemen with their backs up against the wall economically. We’ve got an industry we’re trying to rebuild. We’ve got barns full of 2-year-olds, and they come in this past week and tell the commission, ‘Oh, by the way, we’re not writing 2-year-old races with Lasix. Either you do it our way, or we’re not going to write those races.’ And we have to tell our horsemen now to take their horses out of state.”

Michael Algeo, the MRC chairperson, likened the way the MJC broached the no-Lasix topic as akin to trying to change the rules in the middle of a football game.

“And if you don’t agree with the change of the rules, we’re going to take our ball and go home,” Algeo added.

Algeo made it clear at the outset of the discussion of the agenda item that the June 18 request in the form of a letter from TSG technically came in too late to be considered for the monthly meeting, but he wanted to end up including it because the medication issue was of such importance.

Algeo said the letter, signed by Craig Fravel, TSG’s chief executive of racing operations, stated, “we intend to begin scheduling races for 2-year-olds [without Lasix] and hereby inform the commission that your action is required.”

Algeo said he was “somewhat taken aback” at receiving what appeared to be more of a written directive, rather than a request, from TSG. He noted the letter was accompanied by a press release about the 2-year-old Lasix ban that seemed to suggest the commission’s compliance was a foregone conclusion. Algeo said TSG then submitted a lengthy legal memorandum only 48 hours before the June 25 teleconference, meaning it came in too close to the meeting for commissioners to read and understand in a timely manner.

“That, sir, put us in a very difficult position,” Algeo told Rifkin. He then added in a curt tone that underscored his annoyance, “And it’s a position that I don’t like to be put in.”

Nonetheless, Rifkin was allowed nearly 18 minutes of uninterrupted testimony to state TSG/MJC’s case on not allowing 2-year-olds to race on Lasix.

“We are not asking the commission for a ban on race-day Lasix. We agree with you Mr. Chairman, that is a question for another day,” Rifkin said. “All MJC intends to do here is present the opportunity to owners or trainers who voluntarily wish to race their 2-year-olds drug-free of Lasix…without the competitive disadvantage of other horses using Lasix.”

Rifkin said no new regulation or law would be needed to approve the Lasix-free races for juveniles. He explained that’s because the current Lasix regulations hinge on the word “permissible” and not “mandatory” when describing how the drug is to be used.

“That regulation speaks to what owners and trainers may do. Not what the [MJC] must do,” Rifkin said. “That is, there is nothing in that regulation that requires MJC to run any races for horses using Lasix.”

Rifkin then pointed out that another section of the state’s regulations limit Lasix doses on race day to “not more than 100” nanograms.

“Quite obviously, carding a race with zero nanograms of Lasix as a voluntary condition of entrance is less than the maximum permitted 100 nanograms,” Rifkin said. “That’s entirely consistent with that regulation.”

As for the request coming in only a week before the meeting (and after an edition of the MRC agenda had already been publicly noticed), Rifkin said, “I know there is some concern that this has come upon you fast. But it really hasn’t in some respects. The debate over Lasix has been here for awhile.

“We submit that MJC has a legitimate business reason and absolute right to conduct drug-free races,” Rifkin continued. “There is no law, regulation, or condition that prohibits that action, [and that the 2-year-old Lasix ban] is in the best public interest of equine safety and the public’s general interest.

“While it may be permissible–in other words voluntary–for an owner or trainer to administer Lasix, it does not mean the track licensee is obligated to be an accomplice and run races for the benefit of those horses who have been administered the drug.

“The action we are taking here is modest,” Rifkin summed up. “The action we are taking here is a first step.”

Algeo replied that, “I understand what your argument is. I understand your interpretation. With all due respect, I just simply disagree with it.”

Algeo said that according to his interpretation, there is no statutory, case law, or regulatory authority that allows the commission to tell the MJC it can run certain races without Lasix.

“I happen to believe that…the best interests of Maryland racing would be to actually continue racing 2-year-olds with Lasix,” Algeo said.

After Algeo made his points, Rifkin asked for clarification: “Are you telling us we must run races for 2-year-olds with Lasix?”

“No sir,” was Algeo’s reply.

On the heels of that exchange was when Rifkin, in answer to another commissioner’s suggestion that Laurel try carding both Lasix-allowed and Lasix-free juvenile races to see what happens, stated his above-quoted desire by the MJC not to write any 2-year-old races at all under the current circumstances.

Algeo closed the discussion by saying that the commission’s official action on the item for Thursday would be to refer the no-Lasix proposal to the MRC’s newly formed safety and welfare committee, with the request that the issue be expedited so it can be taken up at a future meeting before the full commission.

The post MD Commission Pushes Back on Lasix-Free 2YOs, The Stronach Group Vows to Write No Juvenile Races appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights